NEW YORK (GenomeWeb) – Australian diagnostics manufacturer Genetic Signatures announced today that it has received CE marking for a PCR-based kit to detect extended spectrum beta-lactamase (ESBL) and carbapenemase-producing organisms (CPOs).

The firm's EasyScreen ESBL & CPO Kit detects strains of antibiotic-resistant pathogens, often referred to as "superbugs," in less than three hours with minimal hands-on time. It detects a total of 16 beta-lactam and carbapenem-resistant pathogen targets.